Therapeutics, Prescribing, Interactions and Monitoring
Treatment goals, phases, individual risk–benefit, response, switching, monitoring, withdrawal, special populations, emergencies and interaction management.
How to prepare for MRCPsych Paper A
Build mechanisms first, connect them to development and assessment, then practise distinguishing one best answer within SBA and extended-matching formats.
Core concepts
Concept 1
Therapeutics joins diagnosis, illness phase, target outcomes, dose, time course, physical health, comedication, individual preference and monitoring.
Exam cue: State the treatment goal and review time before choosing dose, monitoring and the next decision.
Concept 2
Switching, augmentation, withdrawal, special populations, emergencies and interactions require planned sequencing and reassessment rather than isolated drug facts.
Exam cue: For an interaction, distinguish pharmacokinetic exposure change from pharmacodynamic additive or opposing effects.
Risk pitfalls and guardrails
Calling treatment ineffective before adequate dose, duration, adherence and diagnosis have been assessed.
Guardrail: Do not select an option because it is merely associated or familiar; choose the one that answers the exact lead-in.
Switching or stopping without accounting for half-life, withdrawal, relapse and overlapping toxicity.
Guardrail: Do not select an option because it is merely associated or familiar; choose the one that answers the exact lead-in.
Memory anchors
What defines an adequate treatment trial?
An appropriate indication, dose, duration, adherence and outcome assessment, adjusted for tolerability and individual context.
How do pharmacokinetic and pharmacodynamic interactions differ?
Pharmacokinetic interactions change exposure; pharmacodynamic interactions change combined effect without necessarily changing concentration.
What belongs in a monitoring plan?
Baseline risk, benefit target, adverse effects, physical measures, tests, frequency, responsibility and action thresholds.
Why plan withdrawal?
Gradual, monitored change may reduce withdrawal effects, detect relapse early and preserve safety and engagement.
What changes prescribing in special populations?
Developmental physiology, frailty, pregnancy, organ function, comorbidity, polypharmacy, capacity, support and evidence limitations.
Checkpoint rule
Do the check-up only after you can summarize each concept in one sentence and identify one dangerous pitfall from memory.
Knowledge Check (after reading)
Short check-up to confirm understanding of this module.
Check-up Questions
Before prescribing, the clinician agrees with the patient which symptoms and functional outcomes treatment should target. What principle is this?
Why may a lower dose be required in an older adult?
Answer all questions to submit.
Next step personalized recommendations
Continue learning
Move forward only after this module is stable.
What is Pass Harbor?
Completely free exam prep for 247 UK exams.
- Practice questions
- Flashcards
- Study guides
- Mock exams
- No registration
- No paywall
- Start instantly
“No more expensive exam prep. Quality study tools should be accessible to everyone.”